National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 15798-15799 [2015-06699]
Download as PDF
<![CDATA[
15798
Federal Register / Vol. 80, No. 57 / Wednesday, March 25, 2015 / Notices
startres.aspx?EICode=3132&
Attcode=72.
The Marriott Bethesda North Hotel
and Conference Center has a limited
number of rooms available at the
discounted rate of $199 per night until
April 3, 2015, or until the block is filled.
To receive this rate, attendees are asked
to make reservations using the link to
the hotel reservation page or by calling
855–355–0302 or 212–532–1660. If
calling, please select the first option for
‘‘Hotel Reservations’’ and inform the
phone agent that you are making a
reservation for ‘‘Event #15008’’.
If you need special accommodations
because of disability, please contact
Ellen.Diegel@diahome.org at least 7
days before the meeting.
Dated: March 19, 2015.
Leslie Kux,
Associate Commissioner for Policy.
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
rljohnson on DSK3VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Epilepsy Clinical Trial
Review.
Date: April 22, 2015.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: William C. Benzing, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
NINDS/NIH/DHHS/Neuroscience Center,
6001 Executive Boulevard, Suite 3208, MSC
9529, Bethesda, MD 20892–9529, 301–496–
0660, benzingw@mail.nih.gov.
15:26 Mar 24, 2015
Jkt 235001
Dated: March 19, 2015.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–06841 Filed 3–24–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
[FR Doc. 2015–06702 Filed 3–24–15; 8:45 am]
VerDate Sep<11>2014
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
The meeting announced below
concerns Using Longitudinal Data to
Characterize the Natural History of
Fragile X Syndrome to Improve Services
and Outcomes, DD15–003, initial
review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 10:00 a.m.–6:00 p.m., April
14, 2015 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters for Discussion: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Using Longitudinal Data to
Characterize the Natural History of Fragile X
Syndrome to Improve Services and
Outcomes, DD15–003, initial review.’’
Contact Person for More Information: M.
Chris Langub, Ph.D., Scientific Review
Officer, CDC, 4770 Buford Highway NE.,
Mailstop F–80, Atlanta, Georgia 30341,
Telephone: (770) 488–3585, EEO6@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office Centers for Disease Control
and Prevention.
[FR Doc. 2015–06849 Filed 3–24–15; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases, Special
Emphasis Panel; Loan Repayment Program
(LRP).
Date: April 20–24, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892, (Virtual
Meeting).
Contact Person: Maryam Feili-Hariri,
Ph.D., Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, National Institutes of Health/
NIAID, 5601 Fishers Lane, Rockville, MD
20852, 240–669–5026, haririmf@
niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases, Special
Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01).
Date: April 20, 2015.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Room
3F100, 5601 Fishers Lane, Rockville, MD
20852, (Telephone Conference Call).
Contact Person: Jane K. Battles, Ph.D.,
Scientific Review Officer, Scientific Review
Program DEA/NIAID/NIH/DHHS, 5601
Fishers Lane, Rockville, MD 20852, 240–669–
5029, battlesja@mail.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases, Special
Emphasis Panel; NIAID Peer Review Meeting.
Date: April 23, 2015.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Betty Poon, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
E:\FR\FM\25MRN1.SGM
25MRN1
15799
Federal Register / Vol. 80, No. 57 / Wednesday, March 25, 2015 / Notices
Room # 3E72 National Institutes of Health/
NIAID, 5601 Fishers Lane, MSC 9823,
Rockville, MD 20892, 240–669–5024,
poonb@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: March 19, 2015.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–06699 Filed 3–24–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; Generic Clearance
for the Collection of Qualitative
Feedback on Agency Service Delivery
(NINR)
Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below. This proposed information
collection was previously published in
the Federal Register on December 30,
2014 page 43609 and allowed 60-days
for public comment. No public
comments were received. The purpose
of this notice is to allow an additional
30 days for public comment. The
National Institute of Nursing Research,
National Institutes of Health, may not
conduct or sponsor, and the respondent
is not required to respond to, an
information collection that has been
extended, revised, or implemented on or
after October 1, 1995, unless it displays
a currently valid OMB control number.
SUMMARY:
customer or stakeholder perceptions,
experiences and expectations, provide
an early warning of issues with service,
or focus attention on areas where
communication, training or changes in
operations might improve delivery of
products or services. These collections
will allow for ongoing, collaborative and
actionable communications between the
Agency and its customers and
stakeholders. It will also allow feedback
to contribute directly to the
improvement of program management.
Feedback collected under this generic
clearance will provide useful
information, but it will not yield data
that can be generalized to the overall
population. This type of generic
clearance for qualitative information
will not be used for quantitative
information collections that are
designed to yield reliably actionable
results, such as monitoring trends over
time or documenting program
performance. Such data uses require
more rigorous designs that address: the
target population to which
generalizations will be made, the
sampling frame, the sample design
(including stratification and clustering),
the precision requirements or power
calculations that justify the proposed
sample size, the expected response rate,
methods for assessing potential nonresponse bias, the protocols for data
collection, and any testing procedures
that were or will be undertaken prior
fielding the study. Depending on the
degree of influence the results are likely
to have, such collections may still be
eligible for submission for other generic
mechanisms that are designed to yield
quantitative results.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
1,025.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs, OIRA_submission@
omb.eop.gov or by fax to 202–395–6974,
Attention: NIH Desk Officer.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30-days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments or request more
information on the proposed project
contact: Dr. Rebecca Hawes, Division of
Science Policy and Public Liaison,
NINR, NIH, Democracy One, 6701
Democracy Blvd., Suite 710, Bethesda,
MD 20892, by phone at (301) 594–0791
or email your request, including your
address to: hawesr@mail.nih.gov.
Formal requests for additional plans and
instruments must be requested in
writing.
Proposed Collection: Generic
Clearance for the Collection of
Qualitative Feedback on Agency Service
Delivery, 0925–0653, Extension,
National Institute of Nursing Research,
National Institutes of Health (NIH).
Need and Use of Information
Collection: The information collection
activity will garner qualitative customer
and stakeholder feedback in an efficient,
timely manner, in accordance with the
Administration’s commitment to
improving service delivery. By
qualitative feedback we mean
information that provides useful
insights on perceptions and opinions,
but are not statistical surveys that yield
quantitative results that can be
generalized to the population of study.
This feedback will provide insights into
ESTIMATED ANNUALIZED BURDEN HOURS
Type of
respondent
rljohnson on DSK3VPTVN1PROD with NOTICES
Form name
Focus Groups ......................................................................
Individual In-Depth Interviews .............................................
Individual Brief Interviews ....................................................
Customer Satisfaction Surveys ...........................................
Small Group Discussions ....................................................
Conferences and Training Pre- and Post-Surveys .............
Web site Usability Testing ...................................................
Pilot Testing Surveys ...........................................................
VerDate Sep<11>2014
15:26 Mar 24, 2015
Jkt 235001
PO 00000
Adults
Adults
Adults
Adults
Adults
Adults
Adults
Adults
Frm 00058
Number of
respondents
.............
.............
.............
.............
.............
.............
.............
.............
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
150
75
200
200
100
500
100
150
E:\FR\FM\25MRN1.SGM
1
1
1
1
1
1
1
1
25MRN1
Average
burden per
response
(in hours)
90/60
1
15/60
15/60
90/60
30/60
90/60
30/60
Total annual
burden hours
225
75
50
50
150
250
150
75
]]>Agencies
[Federal Register Volume 80, Number 57 (Wednesday, March 25, 2015)]
[Notices]
[Pages 15798-15799]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-06699]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases, Special Emphasis Panel; Loan Repayment Program (LRP).
Date: April 20-24, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 5601 Fishers Lane,
Rockville, MD 20892, (Virtual Meeting).
Contact Person: Maryam Feili-Hariri, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, National Institutes of Health/NIAID, 5601 Fishers Lane,
Rockville, MD 20852, 240-669-5026, haririmf@niaid.nih.gov.
Name of Committee: National Institute of Allergy and Infectious
Diseases, Special Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01).
Date: April 20, 2015.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Room 3F100, 5601 Fishers
Lane, Rockville, MD 20852, (Telephone Conference Call).
Contact Person: Jane K. Battles, Ph.D., Scientific Review
Officer, Scientific Review Program DEA/NIAID/NIH/DHHS, 5601 Fishers
Lane, Rockville, MD 20852, 240-669-5029, battlesja@mail.nih.gov.
Name of Committee: National Institute of Allergy and Infectious
Diseases, Special Emphasis Panel; NIAID Peer Review Meeting.
Date: April 23, 2015.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 5601 Fishers Lane,
Rockville, MD 20852, (Telephone Conference Call).
Contact Person: Betty Poon, Ph.D., Scientific Review Officer,
Scientific Review Program, Division of Extramural Activities,
[[Page 15799]]
Room # 3E72 National Institutes of Health/NIAID, 5601 Fishers Lane,
MSC 9823, Rockville, MD 20892, 240-669-5024, poonb@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: March 19, 2015.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-06699 Filed 3-24-15; 8:45 am]
BILLING CODE 4140-01-P
